You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
17 November 2025 - Biopharmaceutical company Incyte (Nasdaq:INCY) announced on Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Minjuvi (tafa...
17 November 2025 - China-based biopharmaceutical company Shanghai Henlius Biotech Inc (HK:2696) and US healthcare company Organon (NYSE:OGN) announced on Monday that the US Food and Drug Administration (FDA) has approved POHERDY (pertuzumab-dpzb) 420...
17 November 2025 - BodyLogicMD, a provider of bioidentical hormone replacement therapy (BHRT), integrative medicine and weight loss treatment, said on Friday that it completely supports the recommendation to remove black box warnings on certain forms...
17 November 2025 - Fondazione Telethon, an Italy-based non-profit biomedical organisation, announced on Friday that it has received positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP)...
17 November 2025 - * Maxx Orthopedics has announced the latest addition to its expanding Libertas® Hip Portfolio, securing FDA 510(k) clearance for the Libertas® Bipolar Hip System. This development further broadens the company's suite o...
14 November 2025 - Ionis Pharmaceuticals Inc (Nasdaq:IONS), a US-based provider of RNA-targeted medicines, and Japanese healthcare company Otsuka Pharmaceutical Co Ltd announced on Friday that the Committee for Medicinal Products for Human Use (CHMP)...
13 November 2025 - Chinese biotechnology company Ascletis Pharma Inc (HKEX:1672) announced on Wednesday the co-formulation of ASC36, a once-monthly next-generation amylin receptor agonist, and ASC35, a once-monthly next-generation GLP-1R/GIPR dual ag...